Lv1
80 积分 2025-02-15 加入
First and Second-line Treatments in Metastatic Renal Cell Carcinoma
16天前
已完结
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial
16天前
已完结
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection
16天前
已完结
Risk of cardiovascular disease following degarelix versus gonadotropin-releasing hormone agonists in patients with prostate cancer: a systematic review and meta-analysis
16天前
已完结
Epidemiology, diagnosis and treatment of anterior prostate cancer
2个月前
已完结
Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma
2个月前
已关闭
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
2个月前
已完结
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016
2个月前
已关闭
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
2个月前
已完结
Regulation of the Hypoxia-Inducible Factor (HIF) by Pro-Inflammatory Cytokines
皖公网安备34019202002308
